| scholarly article | Q13442814 |
| P50 | author | Xiaoren Tang | Q40174231 |
| P2093 | author name string | Y Yang | |
| M Asano | |||
| S Amar | |||
| A O'Reilly | |||
| A Farquhar | |||
| P2860 | cites work | The conserved CPH domains of Cul7 and PARC are protein-protein interaction modules that bind the tetramerization domain of p53 | Q24297104 |
| Regulation of human p53 activity and cell localization by alternative splicing | Q24302205 | ||
| LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines | Q24555748 | ||
| Structural evolution of p53, p63, and p73: Implication for heterotetramer formation | Q27657730 | ||
| Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain | Q27860534 | ||
| Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways | Q27863390 | ||
| Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2 | Q28609844 | ||
| p53: puzzle and paradigm | Q29618407 | ||
| Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms | Q30436152 | ||
| MCP1 directs trafficking of hematopoietic stem cell-derived fibroblast precursors in solid tumor | Q33745252 | ||
| Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth. | Q33803085 | ||
| Regulation of MCP-1 chemokine transcription by p53 | Q33828413 | ||
| High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals. | Q33873710 | ||
| Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-J | Q33997038 | ||
| The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. | Q34045809 | ||
| Tight DNA binding and oligomerization are dispensable for the ability of p53 to transactivate target genes and suppress transformation. | Q34055161 | ||
| The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis | Q34122715 | ||
| HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels | Q34161535 | ||
| The role of tetramerization in p53 function | Q34290217 | ||
| A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint | Q34432975 | ||
| The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. | Q34498861 | ||
| Chemokines as novel therapeutic targets in inflammatory diseases | Q34605411 | ||
| Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis | Q35788653 | ||
| Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression | Q36698048 | ||
| Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity | Q37401453 | ||
| Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone | Q37431256 | ||
| Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents | Q37668316 | ||
| NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. | Q38304810 | ||
| The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator | Q38306731 | ||
| Lipopolysaccharide of Burkholderia cepacia and its unique character to stimulate murine macrophages with relative lack of interleukin-1beta-inducing ability | Q39520445 | ||
| A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis | Q39763545 | ||
| The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis. | Q39806223 | ||
| Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis | Q39808249 | ||
| Chemotherapeutic drugs and human tumor cells cytokine network | Q39951513 | ||
| Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin. | Q40007507 | ||
| Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by toll-like receptor 4, NF-kappaB, and mitogen-activated protein kinases | Q40034111 | ||
| p53 short peptide (p53pep164) regulates lipopolysaccharide-induced tumor necrosis factor-alpha factor/cytokine expression | Q40174140 | ||
| Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B). | Q40567462 | ||
| DNA-Protein Interactions in the Proximal ζ-Globin Promoter: Identification of Novel CCACCC- and CCAAT-binding Proteins | Q41030725 | ||
| Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study | Q42087576 | ||
| Transcription factor activating protein-2beta: a positive regulator of monocyte chemoattractant protein-1 gene expression | Q42806007 | ||
| Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript. | Q42862265 | ||
| Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent | Q43108484 | ||
| Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer | Q43184300 | ||
| Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats | Q44183029 | ||
| The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. | Q44192183 | ||
| Astrocyte differentiation selectively upregulates CCL2/monocyte chemoattractant protein-1 in cultured human brain-derived progenitor cells. | Q44729461 | ||
| Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition | Q44772848 | ||
| Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells. | Q44796898 | ||
| Sphingosine kinase-1 mediates TNF-alpha-induced MCP-1 gene expression in endothelial cells: upregulation by oscillatory flow | Q44932366 | ||
| CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. | Q45420445 | ||
| Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy | Q45888903 | ||
| Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy | Q46092513 | ||
| Peptides derived from serum amyloid A prevent, and reverse, aortic lipid lesions in apoE-/- mice | Q46630363 | ||
| Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice | Q47990486 | ||
| HIV-1 Nef upregulates CCL2/MCP-1 expression in astrocytes in a myristoylation- and calmodulin-dependent manner. | Q48394729 | ||
| MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion | Q48511851 | ||
| p53 domains: identification and characterization of two autonomous DNA-binding regions | Q52544476 | ||
| Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoform | Q54382805 | ||
| p53 is a suppressor of inflammatory response in mice. | Q54672229 | ||
| Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice | Q58149069 | ||
| Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes | Q72717877 | ||
| Secretion of monocyte chemoattractant protein-1 (MCP-1) by human mononuclear phagocytes | Q72759216 | ||
| Bleomycin sensitivity of mice expressing dominant-negative p53 in the lung epithelium | Q74787837 | ||
| Regulatory role of p53 in experimental autoimmune encephalomyelitis | Q78952331 | ||
| A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia | Q79834476 | ||
| Pulmonary chemokine expression is coordinately regulated by STAT1, STAT6, and IFN-gamma | Q81111491 | ||
| Selective CCR2-targeted macrophage depletion ameliorates experimental mesangioproliferative glomerulonephritis | Q82759772 | ||
| The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence | Q82917048 | ||
| p53 peptide prevents LITAF-induced TNF-alpha-mediated mouse lung lesions and endotoxic shock | Q84334037 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 929-943 | |
| P577 | publication date | 2012-09-01 | |
| P1433 | published in | Current Molecular Medicine | Q5195065 |
| P1476 | title | p53 is an important regulator of CCL2 gene expression | |
| P478 | volume | 12 |
| Q38619367 | Agmatine Ameliorates High Glucose-Induced Neuronal Cell Senescence by Regulating the p21 and p53 Signaling |
| Q28397726 | Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis |
| Q38751550 | CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma |
| Q100467652 | Deficiency of miR-208a Exacerbates CCl4-Induced Acute Liver Injury in Mice by Activating Cell Death Pathways |
| Q90657242 | Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis |
| Q27003079 | Immune surveillance of unhealthy cells by natural killer cells |
| Q34482050 | Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression. |
| Q35133888 | Oral bacteria and cancer |
| Q92145315 | Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer |
| Q88768084 | TP53 gain-of-function mutation promotes inflammation in glioblastoma |
| Q33587770 | The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells |
| Q34531766 | Total adiponectin, but not inflammatory markers C-reactive protein, tumor necrosis factor-α, interluekin-6 and monocyte chemoattractant protein-1, correlates with increasing glucose intolerance in pregnant Chinese-Americans |
| Q38930310 | p53 suppresses CCL2-induced subcutaneous tumor xenograft |
| Q37194949 | p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells |
| Q28394092 | p53/PUMA expression in human pulmonary fibroblasts mediates cell activation and migration in silicosis |
Search more.